{"disease":{"id":"left-ventricular-hypertrophy","name":"left ventricular hypertrophy"},"drugs":{"marketed":[{"drug_id":"chlorothiazide","indication_name":"Hypertension with Left Ventricular Hypertrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diuril","generic_name":"CHLOROTHIAZIDE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"losartan-potassium","indication_name":"Hypertension with Left Ventricular Hypertrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"LOSARTAN POTASSIUM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":69,"revenue":null,"mechanism":"Cozaar works by blocking the action of angiotensin II on its receptor, which helps to relax blood vessels and lower blood pressure."},{"drug_id":"hydrochlorothiazide","indication_name":"Hypertension with Left Ventricular Hypertrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Microzide","generic_name":"hydrochlorothiazide","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"ACE","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure."},{"drug_id":"losartan","indication_name":"Hypertension with Left Ventricular Hypertrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"losartan","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"AT1 receptor","drug_class":"ARB (Angiotensin II receptor blocker)","quality_score":65,"revenue":null,"mechanism":"Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 receptor."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07263204","title":"AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05903313","title":"A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software","phase":"","overall_status":"UNKNOWN","enrollment_count":4306,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05942729","title":"Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04275882","title":"Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy","phase":"","overall_status":"COMPLETED","enrollment_count":886,"lead_sponsor_name":"Cardiovascular Academy Society, Turkey","has_results":false},{"nct_id":"NCT05719337","title":"Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults","phase":"","overall_status":"UNKNOWN","enrollment_count":660,"lead_sponsor_name":"First Hospital of China Medical University","has_results":false},{"nct_id":"NCT06169358","title":"Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy","phase":"","overall_status":"UNKNOWN","enrollment_count":627,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT05388032","title":"Sodium Lowering Vascular Effects Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"Tulane University","has_results":false},{"nct_id":"NCT05179668","title":"SGLT2 Inhibition in Hemodialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT05726695","title":"The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Hospital Ostrava","has_results":false},{"nct_id":"NCT03322319","title":"Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)","phase":"NA","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"University Hospital Center of Martinique","has_results":false},{"nct_id":"NCT04461041","title":"Empagliflozin and Cardiac Remodelling in People Without Diabetes","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT02973633","title":"Diffusion MRI in Heart Failure","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03666351","title":"Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":false},{"nct_id":"NCT03186742","title":"Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Poznan University of Medical Sciences","has_results":false},{"nct_id":"NCT03759002","title":"Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.","phase":"","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Isfahan University of Medical Sciences","has_results":false},{"nct_id":"NCT07380893","title":"Left Ventricular Hypertrophy in CKD Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT03549559","title":"Imaging Histone Deacetylase in the Heart","phase":"NA","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03332745","title":"Mechanism of Decompensation Evaluation - Aortic Stenosis","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05646056","title":"A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Prolaio","has_results":false},{"nct_id":"NCT03193073","title":"Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient","phase":"NA","overall_status":"SUSPENDED","enrollment_count":80,"lead_sponsor_name":"Omnia Mohammed Hashem","has_results":false},{"nct_id":"NCT05593055","title":"Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04022330","title":"Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03219632","title":"Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Seoul National University Bundang Hospital","has_results":false},{"nct_id":"NCT02956811","title":"Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes?","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"University of Dundee","has_results":false},{"nct_id":"NCT03182699","title":"Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Rainer Oberbauer","has_results":false},{"nct_id":"NCT03489993","title":"FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT06269640","title":"NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}